GLP-3 is a triple hormone agonist that shows promise for weight loss and managing type 2 diabetes by targeting GLP-1, GIP, and GCG receptors. It may help with weight loss by suppressing appetite, regulating metabolism, and improving blood sugar control. GLP-3 also shows potential for improving blood pressure and lipid profiles.

Potential benefits include:

• Significant Weight Loss: Clinical trials have shown substantial weight reductions, with some participants losing up to a quarter of their body weight in under a year, according to a study by Diabetes UK.
• Improved Blood Sugar Control: GLP-3 helps regulate blood sugar levels
• Enhanced Metabolism: It can stimulate metabolic processes to aid in fat breakdown.
• Appetite Suppression: GLP-3 helps individuals feel fuller longer, leading to reduced calorie intake.
• Muscle Preservation: Unlike some other weight loss drugs, GLP-3 may help preserve muscle mass during weight loss.
• Potential for Improved Cardiovascular Health: Studies have shown potential improvements in blood pressure and lipid profiles.
• Reduced Appetite: By stimulating the GLP-1 receptor, GLP-3 helps to slow down the emptying of the stomach and promote feelings of fullness, reducing overall food intake.
• Improve Insulin Sensitivity: By activating GIP and GLP-1 receptors by activating GIP and GLP-1 receptors, GLP-3 can help improve insulin sensitivity, leading to better glucose control.
• Stimulate Fat Burning: By activating CG and GLP-1 receptors by activating GCG and GLP-1 receptors, GLP-3 can help increase the body's metabolic rate, potentially leading to greater fat loss.

* Stacks well with Ipamorelin or Ipamorelin/CJC-1295 or other GHRP